Globus Medical (GMED) PT Raised to $103 at Barclays
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $79.19 -0.05%
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Globus Medical (NYSE: GMED) to $103.00 (from $100.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
